Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Latest News about Spravato
Recent news which mentions Spravato
Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression
July 23, 2024
Tickers
JNJ
NEWS
Tags
Market News
Cannabis
treatment/resistant depression
From
Benzinga
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18, 2024
Tickers
ABBV
AMGN
CURLF
JAZZ
Tags
Emerging Markets
CURLF
Joe Biden
From
Benzinga
Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions
October 17, 2023
Tickers
JNJ
Tags
News
Ketamine Treatment
Spravato
From
Benzinga
Sales Of Johnson & Johnson Esketamine Drug Spravato Rise Nearly 100% Year Over Year
July 20, 2023
Tickers
JNJ
Tags
FDA
Psychedelics
Benzinga
From
Benzinga
Delic Holdings Shares Corporate Updates: Revenues Grow As Ketamine Clinic Chain Continues Expansion
July 22, 2022
Tickers
DELCF
NAD
Tags
Delic Labs
NAD+ infusion therapy
Market News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.